Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $13.19 Consensus PT from Analysts

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) have received a consensus rating of "Reduce" from the fifteen brokerages that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $13.19.

Several analysts have issued reports on the company. Royal Bank of Canada lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating on the stock in a research report on Tuesday, October 22nd. Jefferies Financial Group decreased their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating for the company in a research report on Wednesday, October 23rd. Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Finally, Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st.

Walgreens Boots Alliance Trading Up 10.5 %

Shares of Walgreens Boots Alliance stock traded up $1.02 during trading hours on Friday, hitting $10.72. The company's stock had a trading volume of 23,652,788 shares, compared to its average volume of 26,702,414. The company has a market capitalization of $9.26 billion, a PE ratio of -1.05, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a 50 day moving average of $10.33 and a 200 day moving average of $9.71. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $22.47.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the previous year, the firm posted $0.66 earnings per share. The business's revenue was up 7.6% on a year-over-year basis. Analysts predict that Walgreens Boots Alliance will post 1.6 earnings per share for the current year.

Hedge Funds Weigh In On Walgreens Boots Alliance

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Walgreens Boots Alliance by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock worth $805,506,000 after buying an additional 2,279,495 shares during the period. State Street Corp boosted its holdings in shares of Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock worth $385,258,000 after acquiring an additional 6,569,223 shares during the period. Invesco Ltd. grew its position in shares of Walgreens Boots Alliance by 8.8% in the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after purchasing an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Walgreens Boots Alliance by 5.2% during the fourth quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after purchasing an additional 1,020,587 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.